Shuttle Pharmaceuticals Holdings (SHPH) Total Liabilities (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Total Liabilities history runs 6 years deep, the most recent figure standing at $8.5 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 317.95% year-over-year to $8.5 million; the TTM figure through Mar 2026 stood at $8.5 million (up 317.95% YoY), while the FY2025 annual figure was $8.2 million, up 357.48% from the prior year.
• Total Liabilities was $8.5 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from $8.2 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $8.5 million in Q1 2026 to a low of $975676.0 in Q4 2022.
• Historically, Total Liabilities has averaged $2.7 million across 5 years, with a median of $2.0 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Total Liabilities sank 57.2% in 2022, then jumped 357.48% in 2025.
• A 5-year view of Total Liabilities shows it stood at $975676.0 in 2022, then jumped by 94.32% to $1.9 million in 2023, then decreased by 5.21% to $1.8 million in 2024, then surged by 357.48% to $8.2 million in 2025, then rose by 2.94% to $8.5 million in 2026.
• The last three Total Liabilities figures came in at $8.5 million (Q1 2026), $8.2 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.